Sectors
KAPA
Kairos Pharma, Ltd.
0.24
900 x 0.24
200 x 0.24
bid
ask
+
0.00
1.01%
03:10 PM
timesize
| Ytd | -66.27% | |
| 1y | -82.26% |
0.23
day range
0.25
0.22
52 week range
2.11
| Open | 0.24 | Prev Close | 0.24 | Low | 0.23 | High | 0.25 | Mkt Cap | 5.69M |
| Vol | 304.81K | Avg Vol | 2.21M | EPS | -0.28 | P/E | N/A | Forward P/E | -7.46 |
| Beta | 1.56 | Short Ratio | 0.13 | Inst. Own | 0.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.33 | 200-d Avg | 0.57 | 1yr Est | 9.00 |
| Income Statement | |||
| Operating Expenses | 1.42M | ||
| Research and Development Expense | 619.00K | ||
| Selling, General and Administrative Expense | 798.00K | ||
| Operating Income | -1.42M | ||
| Net Income | -1.39M | ||
| Net Income Common Stock | -1.39M | ||
| Net Income Common Stock (USD) | -1.39M | ||
| Consolidated Income | -1.39M | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | -1.39M | ||
| Earning Before Interest & Taxes (USD) | -1.39M | ||
| Weighted Average Shares | 21.42M | ||
| Weighted Average Shares Diluted | 21.42M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.63M | ||
| Cash and Equivalents (USD) | 2.63M | ||
| Current Assets | 3.17M | ||
| Total Assets | 4.46M | ||
| Current Liabilities | 265.00K | ||
| Total Liabilities | 265.00K | ||
| Accumulated Retained Earnings (Deficit) | -17.30M | ||
| Shareholders Equity | 4.19M | ||
| Shareholders Equity (USD) | 4.19M | ||
| Assets Non-Current | 1.28M | ||
| Trade and Non-Trade Payables | 265.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 22.00K | ||
| Net Cash Flow from Financing | -37.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.05M | ||
| Issuance (Purchase) of Equity Shares | 7.00K | ||
| Net Cash Flow from Operations | -1.01M | ||
| Share Based Compensation | 259.00K | ||